Anouar Alami studied Chemistry at Montpellier II University, France and He received his PhD in 1991. He then joined in 1992 the department of chemistry at the Faculty of Sciences Dhar El Marhaz, Sidi Mohamed Ben Abdellah University (Fez, Morocco). He obtained his state doctorate thesis degree in Organic Chemistry in 1997 at SMBAU. In parallel to all his responsibilities (Head of Department of Chemistry, Responsible for the doctoral training "Bioactive Molecules, Health and Biotechnologies", Director of the Laboratory of organic chemistry, Coordinator of the Bachelor's degree program "Chemistry Sciences"), he had prepared a DEUG (2008) and a License (2010) in Private Law in French and a Master in Economics and Management (2013) at the Faculty of Economics, Law, and Social Sciences of Fez. Concerning the scientific research side, He had published more than 85 research articles indexed in several databases (Scopus, Web of science, Elsevier, Eric, IMIST…).

Dr.Diane Williamson is a Dstl Fellow in Immunology, based at Porton Down. She has worked in R&D (starting in veterinary vaccinology and moving to human vaccines and therapies for serious pathogens) for 30 years. She has published extensively, on the theme of prophylaxis and therapy of serious human diseases for biodefence and emerging pathogens and has worked in the R& D pipeline from discovery to translation to the clinic. Additionally she is currently a Fellow of the Royal Society of Biology and of the Royal College of Pathology and has served as a Trustee and national Education secretary of the British Society for Immunology.

Ali Karami is currently working as a professor of Molecular Biology (Medical Biotechnology), Genetic Engineering and Bioinformatic Research Center of Molecular Biology, Baqyiatallah University of Medical Sciences. Tehran-IRAN. He is working and teaching in areas like Molecular Biotechnology, Rapid Molecular Detection of Infectious Diseases, like PCR, RT PCR, Microarray, Rapid Immunological detection methods, Point of care for detections, Surveillance and molecular Epidemiology of infectious diseases, Novel Vaccines like Recombinant and DNA vaccine and production of Recombinant Protein for Prevention, Detection and Treatment. Other areas that he has been working since last 25 years are Bioinformatics, Genomics, proteomics and System Biology, Biosafety, Biosecurity, Medical Bio-defence, Bioethics and BWC convention.

Antibiotic Resistance, soil bacteria

Zlatko Dembic is a Professor of Immunology, Cell-Biology and Microbiology at University of Oslo. He has been working in science at various institutions in Academia (Medical Faculty, Zagreb, Croatia; Max-Planck Institute for Immunogenetics, Tubingen, Germany; Basel Institute for Immunology, Switzerland; Institute of Immunology, Oslo, Norway) and industry (Roche, Switzerland). He has his expertise in molecular biology shown by over 100 publications to date and a monograph about cytokines in immunology. He is co-inventor of the US patent (Roche) covering the production and use of etanercept (Enbrel), which is a successful (anti-TNF) biological used to treat several autoimmune diseases including rheumatoid arthritis. He was the president of the Norwegian Society for Immunology and Editor-in-chief of the Scand J Immunol (at present, Associate Editor). He is a Visiting Professor of Medicine at medical school in his hometown Rijeka (Croatia).

Immunology, Cell-Biology and Microbiology

Peter Timms is Professor of Microbiology at the University of Sunshine Coast in Queensland, Australia. He is a nationally and internationally renowned microbiologist with specific expertise in the area of Chlamydia. His laboratory is acknowledged as the leading Australian laboratory and one of the leading groups internationally working on all aspects of chlamydial infections. His research group of 12 staff and students is developing vaccines and new diagnostics for chlamydial diseases in humans and animals as well as an improved understanding of chlamydial genomics, cell biology and pathogenicity. The group is widely acknowledged for its major contributions to chlamydial infections in koalas and other wildlife, including the development of a vaccine for koalas. He has published over 250 papers, reviews and book chapters in peer-reviewed international scientific journals.

Chlamydial Infections, Cell biology, Pathogenicity

Professor Paul Van Buynder is a Public Health physician on the Gold Coast and holds an appointment as a Professor in the School of Public Health at Griffith University in Queensland. He is the Immediate pat president of the Australian Immunisation Coalition. He has held previous senior public health positions in a number of Australian states, at the Centre for Infections in the United Kingdom and in two Canadian provinces. He has held personal appointments on the Influenza sub-committees of National Advisory committees in three continents.

vaccine effectiveness studies, and the evaluation of programs and marketing to maximise vaccine coverage

Professor Paul Van Buynder is a Public Health physician on the Gold Coast and holds an appointment as a Professor in the School of Public Health at Griffith University in Queensland. He is the Immediate pat president of the Australian Immunisation Coalition. He has held previous senior public health positions in a number of Australian states, at the Centre for Infections in the United Kingdom and in two Canadian provinces. He has held personal appointments on the Influenza sub-committees of National Advisory committees in three continents. He has over 50 publications.

Vaccine effectiveness studies, and the evaluation of programs and marketing to maximise vaccine coverage

Epidemology, S. pneumoniae

Hanadi Salman Al-Salmi Recently holds the position of Assistant Director of Infection Control and Hospital in Epidemiology at King Faisal Specialist Hospital and Research Center, and a member of the Makkah Region HealthCare Council, Team Leader PCI Standard for Joint Commission Accreditation. At the same time she has done 5 publications in collaboration with different departments and personnel such as: Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection among Healthcare Personnel, CDC, EID Journal, Volume 22, November 2016, Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection Among Healthcare Personnel" to the New England Journal of Medicine,Itemizing the Bundle: Achieving and Maintaining “ZERO” Central Line-Associated Bloodstream Infection For Over A Year in a Tertiary Care Hospital in Saudi Arabia, AJIC and Taking Compliance in Hand – Hand Hygiene and Importance of Education, EMH Magazine UK.

Infectious diseases

Edgar M. Carvalho is Professor of Medicine of the Federal University of Bahia Medical School and Senior Investigator of the Oswaldo Cruz Foundation. He is a clinic immunologist with expertise in the pathogenesis, Immunology and therapy of tropical diseases mainly in leishmaniasis, helminthic infections and Human T cell lymphotropic virus type 1 (HTLV-1 infection). He has developed the facilities to follow a large amount of patients as well as carriers in the endemic areas of the Schistosoma mansoni and Leishmania braziliensis infection and in a HTLV-1 clinic at the University Hospital of Federal University of Bahia.

Imunopathogenesis, host and parasite interaction

Prof. Eliora Ron serves as Scientific Advisor of BioPetroClean. Prof. Ron served as Scientific Director and Member of Scientific Advisory Committee at MIGAL - Galilee Research Institute LTD. until November 7, 2016. Prof. Ron is a Professor of Microbiology at Tel Aviv University. She serves as the author of more than 150 publications and holds several patents. She serves as Chair of Manja and Morris Leigh for Biotechnology and Biophysics. She serves as President of the Federation of European Microbiological Societies and Federation of Israeli Societies of Experimental Biology. Prof. Ron holds a Ph.D. in Microbiology from Harvard University.

Regulation of gene expression, Bacterial virulence, Use of bacteria to combat pollution

Professor Timms is Professor of Microbiology at the University of Sunshine Coast in Queensland, Australia. He is a nationally and internationally renowned microbiologist with specific expertise in the area of Chlamydia. His laboratory is acknowledged as the leading Australian laboratory and one of the leading groups internationally working on all aspects of chlamydial infections. His research group of 12 staff and students is developing vaccines and new diagnostics for chlamydial diseases in humans and animals as well as an improved understanding of chlamydial genomics, cell biology and pathogenicity. The group is widely acknowledged for its major contributions to chlamydial infections in koalas and other wildlife, including the development of a vaccine for koalas. He has published over 250 papers, reviews and book chapters in peer-reviewed international scientific journals.

Chlamydial infections and diagnosis

Luis Ulloa is Associate Professor of Rutgers - New Jersey Medical School, USA. His study focuses on innate immune responses to septic and aseptic conditions and their regulation by the nervous system in experimental models of sepsis and hemorrhage/Resuscitation.

Molecular mechanisms of neuronal modulation of the immune system, Bioelectronic immunology,

João R. Mesquita (D.V.M., M.Sc.; Ph.D.) is a Professor at the Polytechnic Institute of Viseu, Veterinary Section, where he teaches topics within Infectious Diseases for more than 10 years. On the past decade he has focused on Virology, where he has published 44 papers in Scopus indexed Journals. He has won several scientific prizes from different societies and conferences, where he has presented numerous oral and poster presentations.

Animal and human virology and Zoonotic viruses

Director of Infectious Diseases Unit at "Annunziata" Hospital, Cosenza, Italy

HIV infection & STDs, Bacterial and Fungal Infections,Antibiotics and Antifungal therapy.

Pei-Yong Shi, PhD, is I.H. Kempner Professor of Human Genetics, University of Texas Medical Branch, Galveston Texas, USA. He is also adjunct Professor of Emerging Infectious Diseases at the Duke-NUS Graduate Medical School in Singapore and Honorary Professor at the Wuhan Institute of Virology, Chinese Academy of Sciences. He received his Ph.D. in virology in 1996 from Georgia State University. After postdoctoral training at Yale University, he joined Bristol-Myers Squibb as a Principal Scientist to develop HIV and HCV therapeutics from 1998 to 2000. He then moved to the Wadsworth Center, New York State Department of Health, to study West Nile virus. From 2008 to 2015, he served as Dengue Unit Head and Executive Director to lead drug discovery at Novartis Institute for Tropical Diseases. His group developed the first infectious clone of the epidemic strain of West Nile virus, discovered two RNA cap methylation activities of flavivirus NS5 protein, identified essential RNA elements for flavivirus replication, established various platforms for flavivirus vaccine and drug discovery, and pioneered therapeutics development for dengue virus. He has published over 190 peer-reviewed articles and served as Editor (ACS Infectious Diseases, Journal of General Virology, and Nature Vaccine) and Editorial Board member (Journal of Virology, Virology, and Antiviral Research). He is internationally recognized for his scholar and administrative accomplishments at leading research institution, public health sector, and pharmaceutical industry.

Flaviviral infection, Human Diseases, Drug disovery and vaccines for Viral Infections

He has held important positions in academics (JN Medical college, Aligarh; AIIMS, New Delhi; Sharjah Medical College and Mahatma Gandhi Medical University, Jaipur); industrial research (Ranbaxy New Drug Discovery and Fortis Clinical Research Ltd) Diagnostic labs (Religare SRL Diagnostics and Star Metropolis); tertiary care hospital (JN Medical College, AIIMS and Medanta the Medicity) Public Health (CAREC, PAHO/WHO), Public Health Technology Transfer of PHFI. He has published over 100 research papers in peer reviewed international journals, guided over 40 students for their MD/MS/PhD and is named in 30 international patents. He is also the author of NBT sponsored book published by Churchill Livingstone, Antimicrobials in Laboratory Medicine (2000), Has contributed more than a dozen chapters in different books

Medical Microbiology

Associate Director of Clinical Proteomics Core Dept. of Pathology and Laboratory Medicine University of California Health System USA

Disease Biomarkers for Studies on Tuberculosis (TB)

Jintao Li, female, Professor, Director and Principle Investigator, Institute of Tropical Medicine, Third Military Medical University(TMMU). She got her master degree in molecular biology from Biotechnology Centre, Southwest University in 1996 and then became a faculty in Genetics Department, TMMU and got her Ph.D degree in Immunology Institute, PLA, TMMU in 2000 and became associate professor and then professor later since then till to 2013. From 2011-2012, she worked in Canada as a visiting scientist for one year. Now she has published more than 100 academic papers such as Science Translational Medicine, J.I, E.J.I, etc. and got 5 items of awards. Awards and group menberships 2010 Chongqing Natural Science Prize “Antigen immune response regulation” 2009 First class of Chinese medical award “Antigen protein antigenic properties and Engineering Research” 2005 Chongqing natural science prize “Relationship with the immune response to a protein antigen characteristic” 2003 Excellent graduate doctor in TMMU 1993~1996 University first grade Scholarship 1989~1993 University second grade Scholarship

Tropical Pathogens and Epidemiology, Immunology, Biotechnology & Molecular Biology

Thomas D Licker has a BS in Environmental Science from Slippery Rock University and has over 20-years experience in handling event driven hazardous materials and biological response actions. He holds an accredited certification as a Council Certified Environmental Infection Control Remediator recognized by the Council for Engineering and Scientific Boards. He is the Director of Infection Control Technologies, a premier bioremediation services company and serves as the Director of Operations for Decontamination Professionals International.

Infection control technologies

Francis J Castellino is the Kleiderer-Pezold Professor of Biochemistry and Director of the WM Keck Center for Transgene Research at the University of Notre Dame, USA. He has coauthored more that 400 peer reviewed manuscripts.

Hemostasis system

Stef Stienstra is a strategic and creative Consultant in Biomedical Science with a parallel career as a Commander of the reserve of the Royal Dutch Navy. For the Dutch Armed Forces he has responsibility for the counter measures in CBNRe threats and (Medical) consequence management both in a military and a civilian (terrorism) setting. He is a strategic functional specialist for “Health & Environment” of the 1-Civil-Military-Interaction Command (1-CMI) of the Dutch Armed Forces and for 2015 also in the NATO Response Force (NRF), which is in 2015 the responsibility of the 1-German-Netherlands-Corps (1-GNC). In his civil career he works internationally as Consultant or as Scientific Supervisory Board Member for several medical and biotech companies, merely involved in biodefense. He is also a Visiting Professor for Punjab University in Pakistan and Rhein-Waal University in Germany. He has completed his studies in Medicine and in Biochemistry at the University of Groningen in The Netherlands and has extensive practical experience in cell biology, immuno-hematology, biodefense and transfusion medicine. His natural business acumen and negotiation competence helps to initiate new successful businesses, often created out of unexpected combinations of technologies. His good understanding of abstract science combined with excellent skills in the communication of scientific matters to non-specialists, helps him with strategic consulting at top level management.

Ebola

Rachel Groppo has completed her PhD in the laboratory of Dr. Ann Palmenberg at the University of Wisconsin, USA. After completing her Post doctorate at the University of Massachusetts Medical School, she has joined Sanofi Pasteur. Currently she is a Virology Manager at Sanofi Pasteur North American Research.

Virology

Eugenie Bergogne-Berezin is a Professor of Clinical Microbiology at University Diderot, Paris. She has studied MD in Medicine and PhD in Sciences in the early 1970s. She is a Chief of Department of Clinical Microbiology and research group, University Bichat Claude-Bernard and developed research on Acinetobacter spp., (nosocomial pathogen, pathogenicity, resistance), pharmacology of antibiotics, tissue distribution (lungs, brain, bronchi), research on intestinal ecology, jejunal flora and bacterial adhesion. She is an Adviser to pharmaceutical companies, expert in pharmacology-toxicology for the Ministry of Health, expert for international journals. She has developed a journal Antibiotics, (Elsevier). She has published 6 medical books, many chapters in international infectious diseases books, 200 articles in scientific journals.

Antibiotics

Fernanda De Freitas Anibal had her PhD from University of São Paulo, Brazil in Basic and Applied Immunology. She is a Principal Investigator at Laboratory of Parasitology (Federal University of São Carlos) seeks new tools for the treatment, prevention and diagnostics for infectious diseases. Currently, they are working with two plants and six enzymes and their effects against schistosomiasis mansoni and toxocariasis, about the treatment of the infectious diseases, their group studies effects of plants (extracts) and their isolated fractions in order to evaluate the anti-parasitic and anti-inflammatory effects and for infectious disease prevention, moreover have been working on the evaluation of the proteins of the parasite that has been potential to induce immune responses that decrease the parasite burden.

Immune responses

Joanna Zajkowska is currently working at Medical University of Białystok, Poland and carries Clinical Research on infectious diseases, especially on tick-borne diseases and nervous system diseases. She is an expert in internal medicine, infectious diseases, public health and epidemiology. She is a Member of ISW-TBE, Wien Austria (International Scientific Working group on Tick-Borne Encephalitis and ESGBOR (ESCMID-European Society of Clinical Microbiology and Infectious Diseases). She has published more than 200 papers in reputed journals and serving as a Reviewer in many journals.

Tick-borne diseases and nervous system diseases

Ashok Kapse is a consulting Pediatrician practicing in the city of Surat in the Gujarat state of India, besides owning a private pediatric hospital he is also Head of the Pediatric Department at a prestigious Mahavir Super Specialty Hospital. After finishing graduation (MBBS) he did MD in Pediatrics. Initially he has worked as a Professor of Pediatrics at Medical College Surat, later he opted out for private practice however pursued academic interest. He developed special interest and skill in infectious diseases. He is a recipient of many oration awards and delivered hundreds of lectures on dengue, malaria, typhoid and antibiotic uses across India. He has decorated many a posts in medical fields: President of Surat City Branch of Indian Academy of Pediatrics (IAP), President of Gujarat State Branch of IAP and National President of Infectious Diseases Branch of IAP are few of them. He is an avid Clinical Photographer; his photos figure into various books and atlases including the prestigious atlas of infectious diseases published by American Academy of Pediatrics. He has published umpteen articles in peer reviewed journals.

Pediatric infectious diseases

Stephen Mortlock X is the Global Infectious Diseases and Microbiology Liaison at the Q2 Solutions Laboratory in UK. Prior to joining Q2 Solutions, he was the Chief Microbiologist at the Shaukat Khanum Memorial Cancer Hospital and Research Centre in Lahore, Pakistan and was awarded a DSc for his work setting up an antenatal screening program for the indigent population. He with his colleagues has published over 40 papers on an eclectic mix of subjects from enteric pathogens, food science and saliva cotinine. He has also worked for the Health Protection Agency in the UK and spent time in the Middle East.

Global infectious diseases and microbiology

Junie Lia Monica is an MD, Ph D, Professor, Head Microbiology Department, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj Napoca, Romania. She is a Coordinator of resident doctor’s in the Laboratory Medicine specialty and Leadership PhD doctor’s thesis in Medicine field. She is a Board Member of European professional Societies ESCMID (ESGCP Study Groups), Society of Chemotherapy, Scientia Parasitologica Pro Vita and is a Reviewer of international reviews, Member of International organizations, Director/Coordinator in research projects. She has more than 63 papers published in full in international journals and is an editorial board member of national reviews. She is an Organizer/President, Keynote, Invited Speaker and Chair of International and National Congresses.

Microbiology

Maria Luisa G Daroy is a Scientist at the Research and Biotechnology Division of St. Luke’s Medical Center and Assistant Professor in the MS Molecular Medicine Program of the St. Luke’s College of Medicine-WHQ Memorial. She has published more than 20 papers on dengue, Japanese encephalitis, chikungunya, eye infections, dementia, diabetes and coronary artery disease. She was the Chair of the Board of Examiners of the Philippine Academy for Microbiology from 2013-2015 and authored a book chapter on Philippine microbiology research. Researches include dengue, chikungunya, diarrhea, CNS infections, pathogen genomics, antimicrobial resistance, plant antivirals, molecular diagnostics and genetics of CVD, thyroid cancer and dementia.

Dengue, chikungunya, diarrhea , CNS infections, pathogen genomics, antimicrobial resistance, plant antivirals, molecular diagnostics, genetics of CVD, thyroid cancer and dementia

Maria Del Rosario Davalos Gamboa has acquired her Pharmaceutical Biochemistry degree from the University of San Simon. She has started working at the University of San Simon in the Faculty of Medicine at the Laboratory of Nuclear Medicine and later from August 1992 continued working as a Teaching Research Assistant till 1998. From 2009 to 2010, she was the Director of the Research Institute of the Faculty of Dentistry UMSS and in 1997 won a competency exam at the Faculty of Dentistry UMSS in Biochemistry and appointed as a Professor. She is currently a Legal Representative and owner partner (in a greater proportion than 51% of shares) of the International Associated Factory oils and coals SRL ACECAB, in the city of Santa Cruz, Bolivia, whose principal activity is to generate cosmetic oils and charcoal.

Cancer research

M Khalid Ijaz received DVM, MSc (Honors) from University of Agriculture, Faisalabad, Pakistan and completed Ph.D. in Microbiology and Immunology in 1985 at University of Ottawa, Canada. He did his post-doctoral work at the Vaccines and Infectious Disease Organization (VIDO), Canada. Currently, he’s Research Fellow at RB, Montvale, N.J. and Adjunct Associate Professor at The City University of New York (CUNY). His research focuses on human pathogenic microbial agents’ spread via the environment and mitigational role of hygiene agents. He is an active member of various scientific organizations including American Society for Microbiology, American Society for Virology, ASTM-International, Association of Professionals for Infection Control and Epidemiology and International Society for Infectious Diseases.

Human pathogenic microbial agents

Irina Magdalena Dumitru is an MD, PhD, Associate Professor, "Ovidius" University, Constanta, Romania, Faculty of Medicine. Senior Specialist in Infectious Diseases at Clinical Infectious Diseases Hospital, Constanta. Director of research and development (2006 – 2010) at Clinical Infectious Diseases Hospital, Constanta, in present I am Director of Research Department at Ovidius" University” Constanta. In recent years I am focused on the parasitological, tropical diseases, chronic hepatitis and HIV/AIDS research. In present I am NCP Health Romania for Horizon 2020 program. I am involved in many research projects, clinical trials and I have published numerous scientific articles (more than 95 papers and chapters in medical science journals and books). I am president of the Romanian Association of Parasitology, Constanta and I am member of many scientific societies (EACS, IAS, BENA, Romanian Association of Infectious Diseases, Romanian Association of Study Liver, Romanian Society of Microbiology).

Tropical infectious diseases

Stef Stienstra is a strategic and creative Consultant in Biomedical Science with a parallel career as a Commander of the reserve of the Royal Dutch Navy. For the Dutch Armed Forces he has responsibility for the counter measures in CBNRe threats and (Medical) consequence management both in a military and a civilian (terrorism) setting. He is a strategic functional specialist for “Health & Environment” of the 1-Civil-Military-Interaction Command (1-CMI) of the Dutch Armed Forces and for 2015 also in the NATO Response Force (NRF), which is in 2015 the responsibility of the 1-German-Netherlands-Corps (1-GNC). In his civil career he works internationally as Consultant or as Scientific Supervisory Board Member for several medical and biotech companies, merely involved in biodefense. He is also a Visiting Professor for Punjab University in Pakistan and Rhein-Waal University in Germany. He has completed his studies in Medicine and in Biochemistry at the University of Groningen in The Netherlands and has extensive practical experience in cell biology, immuno-hematology, biodefense and transfusion medicine. His natural business acumen and negotiation competence helps to initiate new successful businesses, often created out of unexpected combinations of technologies. His good understanding of abstract science combined with excellent skills in the communication of scientific matters to non-specialists, helps him with strategic consulting at top level management.

Ebola

Amr Ismail is an MBBCh, MSc, MD, MACP, FISQua, FABAM, CHPI, Consultant Dermatologist, received his Doctorate of Dermatology in 1998, Faculty of Medicine, Cairo University, Egypt, Fellow of the American Board of Aesthetic Medicine (ABAM), USA, Fellow of International Society for Quality in Healthcare (ISQua), Ireland, Certified Professional Health Performance Improvement, AIHQ, USA, Member of American College of Health Executives (ACHE), USA and Member of American College of Physicians (ACP).

Vaccines for HFMD

Ashok Kapse is a consulting Pediatrician practicing in the city of Surat in the Gujarat state of India, besides owning a private pediatric hospital he is also Head of the Pediatric Department at a prestigious Mahavir Super Specialty Hospital. After finishing graduation (MBBS) he did MD in Pediatrics. Initially he has worked as a Professor of Pediatrics at Medical College Surat, later he opted out for private practice however pursued academic interest. He developed special interest and skill in infectious diseases. He is a recipient of many oration awards and delivered hundreds of lectures on dengue, malaria, typhoid and antibiotic uses across India. He has decorated many a posts in medical fields: President of Surat City Branch of Indian Academy of Pediatrics (IAP), President of Gujarat State Branch of IAP and National President of Infectious Diseases Branch of IAP are few of them. He is an avid Clinical Photographer; his photos figure into various books and atlases including the prestigious atlas of infectious diseases published by American Academy of Pediatrics. He has published umpteen articles in peer reviewed journals.

Pediatric infectious diseases